Capella BioScience capellabioscience.com


Public lists: Pharma Startups (4729)

Capella BioScience uses technologies to develop novel medicines based on monoclonal antibodies (mAbs) to the next generation of important therapeutic targets in oncology and autoimmune disease.

Capella BioScience uses technologies to develop novel medicines based on monoclonal antibodies (mAbs) to the next generation of important therapeutic targets in oncology and autoimmune disease.

Company (Alive / Active)

Phone:

Fax:

158-160 North Gower Street

London, NW1 2ND
England, United Kingdom

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Capella BioScience $17.8M Mar 8, 2016

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Capella BioScience Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 4 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity Feb 03, 2017 Application